Table 1.
Basic characteristics of the included literature (n = 11).
| Included literature | Topic of literature | Source | Year | Country | Type of literature |
|---|---|---|---|---|---|
| Steven A. Curley (18) | Localized hepatocellular carcinoma: liver-targeted therapy for patients ineligible for surgery and ineligible for localized thermal ablation | UpToDate | 2022 | USA | Clinical decision |
| National Health Commission of the People’s Republic of China Medical Administration (19) | Primary liver cancer diagnosis and treatment guidelines | Medline | 2022 | China | Guideline |
| Chinese Medical Doctor Association interventional physician branch clinical guidelines committee (7) | Clinical practice guidelines for transarterial chemoembolization of hepatocellular carcinoma in China | Medline | 2021 | China | Guideline |
| Paul J. Hesketh (20) | Antiemetic measures of radiotherapy and chemotherapy in cancer patients | ASCO | 2020 | USA | Guideline |
| 2019 Expert Committee of Liver Cancer Clinical Collaboration between Chinese and Western Medicine (21) | Expert consensus on interventional diagnosis and treatment of primary liver cancer | Medline | 2021 | China | Expert consensus |
| Multidisciplinary Collaborative Group of Digestive Tract Tumors, Cancer Hospital of Peking Union Medical College, Chinese Academy of Medical Sciences (22) | Expert guidance on Internet management of common drug treatment-related adverse reactions in patients with liver cancer | CNKI | 2021 | China | Expert consensus |
| Interventional perioperative special Committee of Interventional Physician Branch of Chinese Medical Doctor Association (23) | Expert consensus on perioperative pain management in interventional treatment of liver malignancies | CNKI | 2022 | China | Expert consensus |
| Research group of the National Science and Technology Special Project for the prevention and control of major infectious diseases such as AIDS and viral hepatitis (24) | Expert consensus on the rehabilitation of traditional Chinese and Western medicine after transcatheter arterial chemoembolization for primary liver cancer | CNKI | 2021 | China | Expert consensus |
| Chinese Anticancer Association tumor clinical chemotherapy professional committee (25) | Expert consensus on prevention and treatment of nausea and vomiting related to cancer drug therapy in China | Medline | 2022 | China | Expert consensus |
| Nursing Group, Interventional Medicine Branch of Hubei Medical Association (26) | Expert consensus on perioperative nursing strategy of transcatheter arterial chemoembolization for hepatocellular carcinoma | CNKI | 2022 | China | Expert consensus |
| Sadahisa Ogasawara (27) | Randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization | Cochrane Library | 2018 | China | RCT |
ASCO, American Society of Clinical Oncology.